General Information of Drug Off-Target (DOT) (ID: OTH0PF56)

DOT Name StAR-related lipid transfer protein 5 (STARD5)
Synonyms START domain-containing protein 5; StARD5
Gene Name STARD5
UniProt ID
STAR5_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
2R55
Pfam ID
PF01852
Sequence
MDPALAAQMSEAVAEKMLQYRRDTAGWKICREGNGVSVSWRPSVEFPGNLYRGEGIVYGT
LEEVWDCVKPAVGGLRVKWDENVTGFEIIQSITDTLCVSRTSTPSAAMKLISPRDFVDLV
LVKRYEDGTISSNATHVEHPLCPPKPGFVRGFNHPCGCFCEPLPGEPTKTNLVTFFHTDL
SGYLPQNVVDSFFPRSMTRFYANLQKAVKQFHE
Function May be involved in the intracellular transport of sterols or other lipids. May bind cholesterol or other sterols.
Reactome Pathway
Recycling of bile acids and salts (R-HSA-159418 )

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
13 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of StAR-related lipid transfer protein 5 (STARD5). [1]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of StAR-related lipid transfer protein 5 (STARD5). [2]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of StAR-related lipid transfer protein 5 (STARD5). [3]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of StAR-related lipid transfer protein 5 (STARD5). [4]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of StAR-related lipid transfer protein 5 (STARD5). [5]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of StAR-related lipid transfer protein 5 (STARD5). [6]
Temozolomide DMKECZD Approved Temozolomide decreases the expression of StAR-related lipid transfer protein 5 (STARD5). [7]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of StAR-related lipid transfer protein 5 (STARD5). [8]
Amiodarone DMUTEX3 Phase 2/3 Trial Amiodarone increases the expression of StAR-related lipid transfer protein 5 (STARD5). [9]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 increases the expression of StAR-related lipid transfer protein 5 (STARD5). [11]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of StAR-related lipid transfer protein 5 (STARD5). [12]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the expression of StAR-related lipid transfer protein 5 (STARD5). [13]
Trichostatin A DM9C8NX Investigative Trichostatin A affects the expression of StAR-related lipid transfer protein 5 (STARD5). [14]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of StAR-related lipid transfer protein 5 (STARD5). [10]
------------------------------------------------------------------------------------

References

1 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
2 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
3 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
4 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
5 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
6 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
7 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
8 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
9 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
10 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
11 Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma. Int J Cancer. 2015 May 1;136(9):2055-64.
12 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
13 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
14 A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling. PLoS One. 2017 May 25;12(5):e0178302. doi: 10.1371/journal.pone.0178302. eCollection 2017.